ClinicalTrials.Veeva

Menu

Ultrasound-guided Thermal Ablation for Papillary Thyroid Carcinoma

C

Chinese PLA General Hospital (301 Hospital)

Status

Enrolling

Conditions

Papillary Thyroid Cancer

Treatments

Procedure: ultrasound-guided thermal ablation

Study type

Observational

Funder types

Other

Identifiers

NCT06733740
2024-655

Details and patient eligibility

About

To evaluate long-term outcomes of ultrasound-guided thermal ablation for the treatment of papillary thyroid carcinoma

Full description

To evaluate and predict long-term clinical outcomes of ultrasound-guided thermal ablation for the treatment of papillary thyroid carcinoma by a multicenter study

Enrollment

3,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients age between 18 and 80 year old, both sex
  2. papillary thyroid carcinoma confirmed by core-needle biopsy or fine-needle aspiration
  3. the largest diameter ≤2.0 cm
  4. no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, neck and chest CT
  5. follow-up period ≥12 months

Exclusion criteria

  1. patients with convincing evidence of aggressive papillary thyroid carcinoma or other type of thyroid cancer by biopsy
  2. history of neck radiation
  3. coagulation disorder, serious heart, respiratory, liver, or renal failure
  4. dysfunction of the vocal cord on the opposite side

Trial contacts and locations

1

Loading...

Central trial contact

Lin Yan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems